CLINICAL_TRIALS
ClinicalTrials.gov record update
Feasibility and Efficacy of Transvaginal Botulinum Toxin A Chemodenervation of the Bladder for the Third Line Treatment of Refractory Overactive Bladder
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05463822
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:34.816412+00:00
- Published At
- 2022-07-19T00:00:00+00:00
- Record Updated At
- 2022-07-19
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Overactive Bladder", "Bladder, Overactive", "Urge Incontinence", "Urgency Urinary", "Urinary Frequency/Urgency"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-07-19"- protocolSection.identificationModule.nctId
"NCT05463822"- protocolSection.identificationModule.officialTitle
"Feasibility and Efficacy of Transvaginal Botulinum Toxin A Chemodenervation of the Bladder for the Third Line Treatment of Refractory Overactive Bladder"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.